Nuclear Medicine: Page 143

Researchers dial back FDG activity to reduce PET/MRI dose

By Wayne Forrest

European researchers have set the groundwork for what they believe is a feasible way to achieve optimal image quality in PET/MRI scans: balancing lower radiotracer dose with prolonged PET image acquisition time to match the longer duration needed for MR image acquisition.

August 20, 2014

Piramal marks Neuraceq 1st commercial U.S. use

By AuntMinnie.com staff writers

Piramal Imaging said that WVU Healthcare in West Virginia is the first center in the U.S. to perform commercial scans using its Neuraceq radiopharmaceutical.

August 20, 2014

Aeolus submits IND for radiation protection drug

By AuntMinnie.com staff writers

Aeolus Pharmaceuticals has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration to begin a phase I study of a radiation protection drug.

August 20, 2014

NorthStar, GE sign moly supply deal

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes has signed a nonexclusive letter of intent with GE Healthcare to supply GE with molybdenum-99.

August 13, 2014

Lantheus trims loss in Q2

By AuntMinnie.com staff writers

Growth in its U.S. ultrasound contrast business contributed to a 7% increase in revenue for Lantheus Medical Imaging in its second quarter.

August 12, 2014

Circulation: Little radiation risk seen in cardiac scans

By Eric Barnes

A lack of demonstrated harms combined with significant recent dose reductions have led at least one group of cardiovascular imaging specialists to worry less about the risks of a heart scan and more about the well-being of the patient, according to a new review article in Circulation.

August 10, 2014